NutriSystem (NASDAQ:NTRI) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday.
A number of other equities analysts also recently commented on the stock. Zacks Investment Research downgraded shares of NutriSystem from a “buy” rating to a “hold” rating in a research note on Wednesday, August 1st. Barrington Research restated a “hold” rating on shares of NutriSystem in a research note on Wednesday, August 1st. ValuEngine upgraded shares of NutriSystem from a “strong sell” rating to a “sell” rating in a research note on Friday, August 3rd. B. Riley increased their price objective on shares of NutriSystem from $52.00 to $53.00 and gave the stock a “buy” rating in a research note on Tuesday, July 31st. Finally, DA Davidson downgraded shares of NutriSystem from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $45.00 to $40.00 in a research note on Tuesday, July 31st. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company’s stock. NutriSystem has a consensus rating of “Hold” and an average target price of $46.50.
Shares of NASDAQ NTRI opened at $37.10 on Friday. The firm has a market capitalization of $1.09 billion, a P/E ratio of 18.93, a P/E/G ratio of 1.78 and a beta of 1.27. NutriSystem has a 1-year low of $26.06 and a 1-year high of $60.80.
NutriSystem (NASDAQ:NTRI) last announced its earnings results on Monday, July 30th. The company reported $0.87 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.81 by $0.06. The firm had revenue of $191.30 million during the quarter, compared to analyst estimates of $189.07 million. NutriSystem had a net margin of 7.94% and a return on equity of 43.29%. The company’s revenue for the quarter was down 1.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.80 EPS. Analysts predict that NutriSystem will post 2.09 earnings per share for the current year.
Institutional investors have recently bought and sold shares of the company. Atria Investments LLC acquired a new position in shares of NutriSystem during the 2nd quarter worth about $394,000. First Mercantile Trust Co. acquired a new position in shares of NutriSystem during the 2nd quarter worth about $119,000. Aperio Group LLC acquired a new position in shares of NutriSystem during the 2nd quarter worth about $313,000. Guggenheim Capital LLC boosted its stake in shares of NutriSystem by 8.3% during the 1st quarter. Guggenheim Capital LLC now owns 56,018 shares of the company’s stock worth $1,509,000 after buying an additional 4,308 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of NutriSystem during the 2nd quarter worth about $259,000.
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.
Featured Article: Stock Symbol
Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.